Andrew R. Allen
2014
In 2014, Andrew R. Allen earned a total compensation of $3.9M as Former EVP of Clinical and Pre-Clinical Development and Chief Medical Officer at Clovis Oncology, a 133% increase compared to previous year.
Compensation breakdown
| Bonus | $202,500 |
|---|---|
| Option Awards | $3,222,177 |
| Salary | $441,350 |
| Other | $15,474 |
| Total | $3,881,501 |
Allen received $3.2M in option awards, accounting for 83% of the total pay in 2014.
Allen also received $202.5K in bonus, $441.4K in salary and $15.5K in other compensation.
Rankings
In 2014, Andrew R. Allen's compensation ranked 2,201st out of 13,032 executives tracked by ExecPay. In other words, Allen earned more than 83.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,201 out of 13,032 | 83rd |
Division Manufacturing | 783 out of 4,965 | 84th |
Major group Chemicals And Allied Products | 249 out of 1,690 | 85th |
Industry group Drugs | 193 out of 1,369 | 86th |
Industry Pharmaceutical Preparations | 159 out of 1,042 | 85th |
Source: SEC filing on April 27, 2016.
Allen's colleagues
We found four more compensation records of executives who worked with Andrew R. Allen at Clovis Oncology in 2014.